Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 2011 AL 2025

Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders

Hölscher C.

Br J Pharmacol. 2022 Feb;179(4):695-714. doi: 10.1111/bph.15508. Epub 2021 May 29.

Prolactin and Its Altered Action in Alzheimer's Disease and Parkinson's Disease

Duc Nguyen H, Pal Yu B, Hoang NHM, Jo WH, Young Chung H, Kim MS.

Neuroendocrinology. 2022;112(5):427-445. doi: 10.1159/000517798. Epub 2021 Jun 14.

T Cells: A Growing Universe of Roles in Neurodegenerative Diseases

Dressman D, Elyaman W.

Neuroscientist. 2022 Aug;28(4):335-348. doi: 10.1177/10738584211024907. Epub 2021 Jun 23.

Traumatic Brain Injury and Risk of Neurodegenerative Disorder

Brett BL, Gardner RC, Godbout J, Dams-O'Connor K, Keene CD.

Biol Psychiatry. 2022 Mar 1;91(5):498-507. doi: 10.1016/j.biopsych.2021.05.025. Epub 2021 Jun 2.

Effectiveness of gait aid prescription for improving spatiotemporal gait parameters and associated outcomes in community-dwelling older people: a systematic review

Lee DA, Dissanayaka T, Burton E, Meyer C, Hunter SW, Suttanon P, Ekegren CL, Stout JC, Dawes H, Hill KD.

Disabil Rehabil. 2022 Oct;44(21):6139-6154. doi: 10.1080/09638288.2021.1958930. Epub 2021 Aug 10.

Multimodal retinal imaging to detect and understand Alzheimer's and Parkinson's disease

Moons L, De Groef L.

Curr Opin Neurobiol. 2022 Feb;72:1-7. doi: 10.1016/j.conb.2021.07.007. Epub 2021 Aug 14.

Src family kinases (SFKs): critical regulators of microglial homeostatic functions and neurodegeneration in Parkinson's and Alzheimer's diseases

Portugal CC, Almeida TO, Socodato R, Relvas JB.

FEBS J. 2022 Dec;289(24):7760-7775. doi: 10.1111/febs.16197. Epub 2021 Oct 4.

Are Care-Recipient Outcomes Attributable to Improved Caregiver Well-Being? A Cluster-Randomized Controlled Trial of Benefit-Finding Intervention

Cheng ST, Chan WC, Lam LCW.

Am J Geriatr Psychiatry. 2022 Aug;30(8):903-913. doi: 10.1016/j.jagp.2021.08.009. Epub 2021 Aug 28.

Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment

Pathak N, Vimal SK, Tandon I, Agrawal L, Hongyi C, Bhattacharyya S.

Metab Brain Dis. 2022 Jan;37(1):67-104. doi: 10.1007/s11011-021-00800-w. Epub 2021 Nov 1.

Advancements and future directions in research of the roles of insulin in amyloid diseases

Miller Y.

Biophys Chem. 2022 Feb;281:106720. doi: 10.1016/j.bpc.2021.106720. Epub 2021 Nov 17.

A heterozygous de novo PSEN1 mutation in a patient with early-onset parkinsonism

Chen Y, Liu P, Xie F, Wang B, Lin Z, Luo W.

Neurol Sci. 2022 Feb;43(2):1405-1409. doi: 10.1007/s10072-021-05726-w. Epub 2021 Nov 29.

Lewy Body Dementias: Controversies and Drug Development

Chiu SY, Bowers D, Armstrong MJ.

Neurotherapeutics. 2022 Jan;19(1):55-67. doi: 10.1007/s13311-021-01161-z. Epub 2021 Dec 2.

Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo-Controlled Trial

Biglan K, Munsie L, Svensson KA, Ardayfio P, Pugh M, Sims J, Brys M.

Mov Disord. 2022 Mar;37(3):513-524. doi: 10.1002/mds.28879. Epub 2021 Dec 2.

Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future

Karaboğa MNS, Sezgintürk MK.

J Pharm Biomed Anal. 2022 Feb 5;209:114479. doi: 10.1016/j.jpba.2021.114479. Epub 2021 Nov 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias